- Home
- XWIN vs JSPR Comparison
XWIN vs JSPR Comparison
Compare XWIN & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XWIN
- JSPR
- Stock Information
- Founded
- XWIN 2003
- JSPR 2018
- Country
- XWIN United States
- JSPR United States
- Employees
- XWIN N/A
- JSPR N/A
- Industry
- XWIN Home Furnishings
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XWIN Consumer Discretionary
- JSPR Health Care
- Exchange
- XWIN Nasdaq
- JSPR Nasdaq
- Market Cap
- XWIN 75.2M
- JSPR 68.4M
- IPO Year
- XWIN N/A
- JSPR N/A
- Fundamental
- Price
- XWIN $5.74
- JSPR $1.85
- Analyst Decision
- XWIN
- JSPR Buy
- Analyst Count
- XWIN 0
- JSPR 12
- Target Price
- XWIN N/A
- JSPR $25.60
- AVG Volume (30 Days)
- XWIN 911.6K
- JSPR 419.4K
- Earning Date
- XWIN 11-13-2025
- JSPR 11-10-2025
- Dividend Yield
- XWIN N/A
- JSPR N/A
- EPS Growth
- XWIN N/A
- JSPR N/A
- EPS
- XWIN N/A
- JSPR N/A
- Revenue
- XWIN $16,959,274.00
- JSPR N/A
- Revenue This Year
- XWIN N/A
- JSPR N/A
- Revenue Next Year
- XWIN N/A
- JSPR N/A
- P/E Ratio
- XWIN N/A
- JSPR N/A
- Revenue Growth
- XWIN 70.36
- JSPR N/A
- 52 Week Low
- XWIN $0.39
- JSPR $1.56
- 52 Week High
- XWIN $6.08
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- XWIN N/A
- JSPR 40.83
- Support Level
- XWIN N/A
- JSPR $1.56
- Resistance Level
- XWIN N/A
- JSPR $1.83
- Average True Range (ATR)
- XWIN 0.00
- JSPR 0.19
- MACD
- XWIN 0.00
- JSPR -0.01
- Stochastic Oscillator
- XWIN 0.00
- JSPR 31.10
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.